We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

612 hedge funds and large institutions have $10.7B invested in Charles River Laboratories in 2023 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 252 increasing their positions, 203 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 252 | Existing positions reduced: 203

5% more capital invested

Capital invested by funds: $10.3B → $10.7B (+$474M)

0.21% less ownership

Funds ownership: 100.16% → 99.94% (-0.21%)

8% less first-time investments, than exits

New positions opened: 67 | Existing positions closed: 73

1% less funds holding

Funds holding: 620 → 612 (-8)

16% less call options, than puts

Call options by funds: $29.3M | Put options by funds: $34.8M

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
612
Holders Change
-8
Holders Change %
-1.29%
% of All Funds
9.61%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
67
Increased
252
Reduced
203
Closed
73
Calls
$29.3M
Puts
$34.8M
Net Calls
-$5.51M
Net Calls Change
-$16.3M

Top Buyers

1
BlackRock
BlackRock
New York
+$81.8M
2
AI
Ariel Investments
Illinois
+$72.6M
3
ClearBridge Investments
ClearBridge Investments
New York
+$68.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$50.8M
5
MBI
Montrusco Bolton Investments
Quebec, Canada
+$43.7M

Top Sellers

1
Marshall Wace
Marshall Wace
United Kingdom
-$105M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$79.5M
3
JSP
Jackson Square Partners
California
-$62.2M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$60M
5
FAM
Fred Alger Management
New York
-$44.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$85.1M -$2.34M -11,762 -3%
Luther King Capital Management (LKCM)
27
Luther King Capital Management (LKCM)
Texas
$84.5M -$2.12M -10,656 -3%
SCA
28
Southpoint Capital Advisors
New York
$84.1M – – –
William Blair Investment Management
29
William Blair Investment Management
Illinois
$82.9M -$60M -301,716 -43%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$81M +$6.31M +31,705 +9%
Norges Bank
31
Norges Bank
Norway
$80.6M -$18.4M -92,331 -19%
First Trust Advisors
32
First Trust Advisors
Illinois
$78.8M +$13.4M +67,112 +22%
Victory Capital Management
33
Victory Capital Management
Texas
$77.6M -$800K -4,021 -1%
TGA
34
TPG GP A
Texas
$69.1M +$6.45M +32,402 +11%
RP
35
Riverbridge Partners
Minnesota
$67.5M +$4.41M +22,186 +7%
BG
36
Bellevue Group
Switzerland
$66.1M +$2.4M +12,067 +4%
Legal & General Group
37
Legal & General Group
United Kingdom
$64M -$486K -2,441 -0.8%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$63M -$10.8M -54,252 -15%
CI Investments Inc
39
CI Investments Inc
Ontario, Canada
$62.6M +$1.59M +8,013 +3%
Goldman Sachs
40
Goldman Sachs
New York
$60.1M +$16.4M +82,445 +41%
Primecap Management
41
Primecap Management
California
$57.6M – – –
Neuberger Berman Group
42
Neuberger Berman Group
New York
$55.2M +$425K +2,138 +0.8%
Point72 Asset Management
43
Point72 Asset Management
Connecticut
$53.7M +$50.8M +255,178 New
RJA
44
Raymond James & Associates
Florida
$51.8M +$2.74M +13,793 +6%
HKAM
45
Horizon Kinetics Asset Management
New York
$48.9M -$2.88M -14,468 -6%
Empower Advisory Group
46
Empower Advisory Group
Colorado
$46.2M +$3.65M +18,321 +9%
PFM
47
Premier Fund Managers
United Kingdom
$46M – – –
SCM
48
Soleus Capital Management
Connecticut
$44M +$10.6M +53,400 +34%
Fisher Asset Management
49
Fisher Asset Management
Washington
$42.5M -$2.76M -13,868 -6%
BNP Paribas Asset Management
50
BNP Paribas Asset Management
France
$42.2M +$6.6M +33,172 +20%
1
2
3 4 5

CRL Hedge Fund Activity: Q2 2023 in Review

612 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2023, worth a combined $10.7B — up 4.6% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of CRL and 67 opened new positions — a net loss of 6 holders — while 203 trimmed existing stakes and 252 added.

The largest buyer was BlackRock, adding an estimated $81.8M. The largest seller was Marshall Wace, cutting an estimated $105M.

  • 612 institutional investors held Charles River Laboratories (CRL) as of Q2 2023, down from 620 in Q1 2023.
  • Funds reported $10.7B of Charles River Laboratories stock for Q2 2023, up 4.6% quarter-over-quarter.
  • 67 funds opened new Charles River Laboratories positions in Q2 2023 and 73 closed out, a net change of -6 holders.
  • The largest Charles River Laboratories buyer in Q2 2023 was BlackRock, an estimated $81.8M added.
  • The largest Charles River Laboratories seller in Q2 2023 was Marshall Wace, an estimated $105M sold.

Based on aggregated 13F filings for Q2 2023.